BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5080345)

  • 1. Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria.
    Taljaard JJ; Shanley BC; Stewart-Wynne EG; Deppe WM; Joubert SM
    Br J Dermatol; 1972 Sep; 87(3):261-9. PubMed ID: 5080345
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporation of (4-14 C) -aminolaevulinate into urinary porphyrins in porphyria cutanea tarda: effect of chloroquine therapy.
    Taljaard JJ; Shanley BC; Joubert SM; Deppe WM
    Clin Sci; 1973 Jun; 44(6):571-81. PubMed ID: 4713665
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of porphyria cutanea tarda with chloroquine.
    Kordac V; Semrádová M
    Br J Dermatol; 1974 Jan; 90(1):95-100. PubMed ID: 4811840
    [No Abstract]   [Full Text] [Related]  

  • 4. Porphyria cutanea tarda treated with chloroquine phosphate.
    Bloom M
    Arch Dermatol; 1969 Sep; 100(3):375-6. PubMed ID: 5822385
    [No Abstract]   [Full Text] [Related]  

  • 5. [Purinor in the treatment of porphyria cutanea tarda].
    Capusan I; Opincaru E; Bociat T; Lazar V; Moisi IG
    Z Hautkr; 1974 Jul; 49(13):575-8. PubMed ID: 4421385
    [No Abstract]   [Full Text] [Related]  

  • 6. [Suburoporphyrins in symptomatic hepatic porphyria and in experimental porphyria (author's transl)].
    Kaláb M; Jirsa M; Kordac V; Soldátová H
    Cas Lek Cesk; 1981 Oct; 120(41):1251-4. PubMed ID: 7344798
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
    Swanbeck G; Wennersten G
    Br J Dermatol; 1977 Jul; 97(1):77-81. PubMed ID: 889703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of chloroquine therapy on the level of porphyrins in the liver in symptomatic hepatic porphyria].
    Martásek P; Jirsa M; Kordac V
    Cesk Gastroenterol Vyz; 1982 Jun; 36(3-4):198-205. PubMed ID: 7105200
    [No Abstract]   [Full Text] [Related]  

  • 9. Porphyria cutanea tarda.
    Muhlbauer JE; Pathak MA
    Int J Dermatol; 1979 Dec; 18(10):767-80. PubMed ID: 393641
    [No Abstract]   [Full Text] [Related]  

  • 10. The therapeutic effect of chloroquine. Hepatic recovery in porphyria cutanea tarda.
    Kowertz MJ
    JAMA; 1973 Jan; 223(5):515-9. PubMed ID: 4739135
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of patients with porphyria cutanea tarda with antimalarials].
    Kordac V; Semrádová M
    Cas Lek Cesk; 1973; 112(24):762-5. PubMed ID: 4714507
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chloroquine therapy in porphyria cutanea tarda].
    Snitker G
    Ugeskr Laeger; 1971 Aug; 133(33):1605-10. PubMed ID: 5099470
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda.
    Felsher BF; Redeker AG
    Medicine (Baltimore); 1966 Nov; 45(6):575-83. PubMed ID: 5925910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pyridoxal-5-phosphate in porphyria cutanea tarda].
    Vibrans U; Hilgenfeldt J; Petres J
    Hautarzt; 1972 Apr; 23(4):155-60. PubMed ID: 5048343
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
    Vogler WR; Galambos JT; Olansky S
    Am J Med; 1970 Sep; 49(3):316-21. PubMed ID: 5455563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of the action of chloroquine in porphyria cutanea tarda.
    Scholnick PL; Epstein J; Marver HS
    J Invest Dermatol; 1973 Oct; 61(4):226-32. PubMed ID: 4744026
    [No Abstract]   [Full Text] [Related]  

  • 19. Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects.
    Saltzer EI; Redeker AG; Wilson JW
    Arch Dermatol; 1968 Nov; 98(5):496-8. PubMed ID: 5693347
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene].
    Wainstok de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC
    Acta Physiol Pharmacol Latinoam; 1987; 37(4):541-54. PubMed ID: 3274026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.